Sort by
Refine Your Search
-
. To achieve our objectives, we will use cutting-edge technologies (CITE-seq, RNA-seq, Ribo-seq) and combine analysis in readily available relevant cellular models of cancer-experienced T cells, syngeneic mouse
-
modifications and chromosome biology. Our team is focused on identification and targeting of extrinsic regulators of myeloid malignancies, and is currently composed of 3 principal investigators, 2 associated
Searches related to current modeling
Enter an email to receive alerts for current-modeling positions